1.Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J cancer. 2015;137:2060-71.
2. Kujan O, Farah CS, Johnson NW. Oral and oropharyngeal cancer in the Middle East and North Africa: incidence, mortality, trends, and gaps in public databases as presented to the Global Oral Cancer Forum. Transl Res Oral Oncol. 2017;2:2057178X17698480.
3.Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14-32.
4.Lee C-H, Liu S-Y, Chou K-C, Yeh C-T, Shiah S-G, Huang R-Y, et al. Tumor-Associated Macrophages Promote Oral Cancer Progression Through Activation of the Axl Signaling Pathway. Ann Surg Oncol. 2014;21:1031-7.
5. Gwak JM, Jang MH, Kim D Il, Seo AN, Park SY. Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer. PLoS One. 2015;10:e0125728.
6.Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889-96.
7.Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231-7.
8. Kzhyshkowska J, Riabov V, Gudima A, Wang N, Orekhov A, Mickley A. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.
9.Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, et al. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res. 2007;67:10181-9.
10.Hu W, Li X, Zhang C, Yang Y, Jiang J, Wu C. Tumorassociated macrophages in cancers. Clin Transl Oncol. 2016;18:251-8.
11.Kong L-Q, Zhu X-D, Xu H-X, Zhang J-B, Lu L, Wang WQ, et al. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. PLoS One. 2013;8:e59771.
12.Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, et al. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. 2014;147:1393-404.
13.Ou Y, Kang M, Zhou L, Cheng Z, Tang S, Yu D. Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma. Nan fang yi ke da xue xue bao= J South Med Univ. 2014;34:180-7.
14.Yamagata Y, Tomioka H, Sakamoto K. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. J Oral Maxillofac Surg. 2019;75:2144-53.
15.Yoshikawa K, Mitsunaga S, Kinoshita T, Konishi M, Takahashi S, Gotohda N, et al. Impact of tumor‐associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci. 2012;103:2012-20.
16.Feeney BC. A simple guide to IBM SPSS statistics for version 20.0. Cengage Learn Boston, MA, USA. 2012.
17.Ibrahim AS, Khaled HM, Mikhail NNH, Baraka H, Kamel H. Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014;2014: 437971.
18.Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012;6:126-30.
19.Scott SE, Grunfeld EA, Main J, McGurk M. Patient delay in oral cancer: a qualitative study of patients’ experiences. Psycho‐Oncology J Psychol Soc Behav Dimens Cancer. 2006;15:474-85.
20. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787-95.
21.Wang S, Sun M, Gu C, Wang X, Chen D, Zhao E, et al. Expression of CD 163, interleukin-10, and interferon gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications. Eur J Oral Sci. 2014;122:202-9.
22.Mori K, Hiroi M, Shimada J, Ohmori Y. Infiltration of m2 tumor-associated macrophages in oral squamous cell carcinoma correlates with tumor malignancy. Cancers (Basel). 2011;3:3726-39.
23.He K-F, Zhang L, Huang C-F, Ma S-R, Wang Y-F, Wang W-M, et al. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int. 2014;2014:838632.
24.Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol A J Pathol Soc Gt Britain Irel. 2008;216:15-24.
25.Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem. 2009;284:34342-54.
26.Ferreira FO, Ribeiro FLL, Batista AC, Leles CR, Alencar R de CG, Silva TA. Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma. Tumor Biol. 2008;29:114- 21.
27.Li J, Farthing PM, Thornhill MH. Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein‐1 by tumour necrosis factor‐α and interferon‐γ. J oral Pathol Med. 2000;29:438-44.
28.Forssell J, Öberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clinic cancer res. 2007;13:1472-9.
29.Ming J, Liu K, Hong J, Li X, Li X, Yang L, et al. The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C , plays an important role in Kazakh ESCC invasion and metastasis. Exp Mol Pathol. 2017;102:15-21.
30.Pinto AT, Pinto ML, Cardoso AP, Monteiro C, Pinto MT, Maia AF, et al. Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities. Sci Rep. 2016;6:18765.
31.Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887-904.
32.Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161:205-14.